跳至主要内容
临床试验/NCT03984045
NCT03984045Unknown3 期

Sphenopalatine Ganglion Block for Treating Acute Frontal Migraine Headache in Pediatric Patients

Newark Beth Israel Medical Center1 个研究点 分布在 1 个国家目标入组 72 人开始时间: 2019年6月6日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
3 期
入组人数
72
试验地点
1
主要终点
Time to headache resolution

研究概览

简要总结

This is a randomized double blind trial comparing an intranasal sphenopalatine block with 2% lidocaine to intravenous (0.15 mg/kg, max 10mg) prochlorperazine in patients greater than 10 years of age presenting to a pediatric emergency department with an acute frontal migraine headache.

详细描述

This is a randomized double blind trial comparing an intranasal sphenopalatine block with 2% lidocaine to intravenous (0.15 mg/kg, max 10mg) prochlorperazine in patients greater than 10 years of age presenting to a pediatric emergency department with an acute frontal migraine headache. Excluded populations include those with sickle cell, concern for CNS infection

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

盲法说明

Pharmacy sends down drug and placebo in study preparations for administration.

入排标准

年龄范围
10 Years 至 20 Years(Child, Adult)
性别
All
接受健康志愿者

入选标准

  • Frontal migraine headache

排除标准

  • Non-english speaking
  • Known pregnancy
  • Sickle cell hemaglobinopathy
  • Concern for CNS infection
  • Acute febrile illness
  • non-frontal headaches
  • Concern for increased intracranial pressure

研究组 & 干预措施

SPG block

Experimental

SPG block performed by using qtip applicator soaked in 2% lidocaine and placed posteriorly into nasal cavity where it dwells for up to 30 min

干预措施: Lidocaine topical (Drug)

Control

Active Comparator

Delivered through IV access obtained in all patients.

干预措施: Prochlorperazine Injection (Drug)

结局指标

主要结局

Time to headache resolution

时间窗: treatment start to patient reported resolution, up to 6 hours

Time to headache resolution in emergency department

ED Length of stay

时间窗: Registration to discharge up to 6 hours

treatment to discharge

次要结局

  • 24 hr follow up(1 day)
  • Number of participants with treatment induced side effects(1 day)
  • Patient satisfaction: Rated on a Likert 100 millimeter scale(Within 6 hours from ED registration)
  • Determine adequacy of blinding(Asked at time of patient discharge from the emergency department or at 1 hr.)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Adam B Sivitz, MD

Medical Director Pediatric Emergency Medicine

Newark Beth Israel Medical Center

研究点 (1)

Loading locations...

相似试验